Abstract:The crystal structure of the title compound, C 32 H 28;N 2O 4 was determined by X-ray diffraction method. Crystallographic data are as follows: M r = 504. 59, monoclinic, space group P2 1/c with cell dimensions of a=11. 778(3), b = 8. 416(3), c = 26. 310(6) Å, β = 95. 74(2)° V = 2594.72(2) Å 3, Z = 4, D c = 1. 292g. cm -3, μ =0. 80cm -1, F(000) = 1064, R=0. 045, R w=0. 048 for 1124 reflections with I≥3σ(I). The molecule of the title compound has T style structure. The lactone-benzene group is nearly perpendicular to the xanthene moiety. The C-O bond in the lactone ring is 1. 516(8) Å, which is longer than that in the normal lactone ring, and this indicates severe weakness of the bond.

2-[(5-Chloro-2-hydroxybenzylidene)amino]-3′,6′-bis(diethylamino)spiro[isoindoline-1,9′-xanthen]-3-one

2-[(5-Chloro-2-hydroxybenzylidene)amino]-3&#8242;,6&#8242;-bis(diethylamino)spiro[isoindoline-1,9&#8242;-xanthen]-3-one

2-[(2,4-Dihydroxybenzylidene)amino]-3&#8242;,6&#8242;-bis(ethylamino)spiro[isoindoline-1,9&#8242;-xanthen]-3-one

3&#8242;,6&#8242;-Bis(ethylamino)-2&#8242;,7&#8242;-dimethyl-2-{2-(E)-[(thiophen-2-yl)methylideneamino]ethyl}spiro[isoindoline-1,9&#8242;-xanthen]-3-one methanol monosolvate

3 ',6 '-Bis(Ethylamino)-2 ',7 '-Dimethyl-2-{2-(E)-[(Thiophen-2-Yl)Methylideneamino]Ethyl}Spiro[Isoindo Line-1,9 '-Xanthen]-3-One Methanol Monosolvate

(4Ar,9r,9ar)-7-bromo-9-nitromethyl-2,3,4,4a,9,9a-hexahydro-1h-xanthen-1- One

(+/-)-(3ars,4sr)-9-Chloro-2-(2-Chloro-4-Nitrophenyl)4-(4-Chlorophenyl)-3 A,4-Diethoxy-6,8-Dimethoxy-Chromano[4,3-D]-Delta(1,9b)-1,2,3-Thiadiazoli Ne

(3ar,6s,7s,7ar)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

(±)-(3aRS,4SR)-9-Chloro-2-(2-chloro-4-nitrophenyl)-4-(4-chlorophenyl)-3a,4-diethoxy-6,8-dimethoxychromano[4,3-d]-Δ1,9b-1,2,3-thiadiazoline

(1′S,2′s,5′r)-3-(2-bromopropionyl)-2′-isopropyl-5′-methylspiro[2h-1,3-benzoxazine-2,1′-cyclohexan]-4(3h)-one

(±)‐(3Ars,4sr)‐9‐chloro‐3a,4‐diethoxy‐6,8‐dimethoxy‐2‐(2‐chloro‐4‐nitrophenyl)‐4‐(4‐chlorophenyl)chromano[4,3‐d]‐δ1,9b‐1,2,3‐thiadiazoline

<i>rac</i>-7-[(2<i>E</i>)-But-2-enoyl]-13-chloro-<i>N</i>-cyclohexyl-7,8-dihydro-5<i>H</i>-isochromeno[4,3-<i>c</i>]phenanthridine-8-carboxamide

1-Acetyl-3'-(4-bromophenyl)-3'-chlorospiro[3H-indole-3,2'-oxetan]-2(1H)-one.

Synthesis and structure of 6′-diethylamino-2′-phenacylaminospiro-[isobenzofuran-1(3H) ,9′-[9H]xanthen]3-one

rac-7-[(2E)-But-2-eno-yl]-13-chloro-N-cyclo-hexyl-7,8-dihydro-5H-isochromeno[4,3-c]phenanthridine-8-carboxamide.

N-(2-Bromophenyl)-2-(4,6-Dimethoxy-Pyrimidin-2-Yloxy)Benzylamine

7-(Benzyloxy)Spiro[2h-1,3-Benzoxazine-2,1 '-Cyclohexan]-4(3h)-One

2-(4,6-Dimethoxypyrimidin-2-ylsulfanyl)-N-phenylbenzamide

Rac-7-[(2e)-but-2-enoyl]-13-chloro-n-cyclohexyl-7,8-dihydro-5h-isochromeno[4,3-c]phenanthridine-8-carboxamide

2-(4-Hydroxybiphenyl-3-yl)isoindolin-1-one

2-[(5-Chloro-2-hydroxybenzylidene)amino]-3′,6′-bis(diethylamino)spiro[isoindoline-1,9′-xanthen]-3-one

2-[(5-Chloro-2-hydroxybenzylidene)amino]-3&amp;#8242;,6&amp;#8242;-bis(diethylamino)spiro[isoindoline-1,9&amp;#8242;-xanthen]-3-one

2-[(2,4-Dihydroxybenzylidene)amino]-3&amp;#8242;,6&amp;#8242;-bis(ethylamino)spiro[isoindoline-1,9&amp;#8242;-xanthen]-3-one

3&amp;#8242;,6&amp;#8242;-Bis(ethylamino)-2&amp;#8242;,7&amp;#8242;-dimethyl-2-{2-(E)-[(thiophen-2-yl)methylideneamino]ethyl}spiro[isoindoline-1,9&amp;#8242;-xanthen]-3-one methanol monosolvate

3 ',6 '-Bis(Ethylamino)-2 ',7 '-Dimethyl-2-{2-(E)-[(Thiophen-2-Yl)Methylideneamino]Ethyl}Spiro[Isoindo Line-1,9 '-Xanthen]-3-One Methanol Monosolvate

(4Ar,9r,9ar)-7-bromo-9-nitromethyl-2,3,4,4a,9,9a-hexahydro-1h-xanthen-1- One

(+/-)-(3ars,4sr)-9-Chloro-2-(2-Chloro-4-Nitrophenyl)4-(4-Chlorophenyl)-3 A,4-Diethoxy-6,8-Dimethoxy-Chromano[4,3-D]-Delta(1,9b)-1,2,3-Thiadiazoli Ne

(3ar*,6s*,7s*,7ar*)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

(±)-(3aRS,4SR)-9-Chloro-2-(2-chloro-4-nitrophenyl)-4-(4-chlorophenyl)-3a,4-diethoxy-6,8-dimethoxychromano[4,3-d]-Δ1,9b-1,2,3-thiadiazoline

(1′S,2′s,5′r)-3-(2-bromopropionyl)-2′-isopropyl-5′-methylspiro[2h-1,3-benzoxazine-2,1′-cyclohexan]-4(3h)-one

(±)‐(3Ars,4sr)‐9‐chloro‐3a,4‐diethoxy‐6,8‐dimethoxy‐2‐(2‐chloro‐4‐nitro­phenyl)‐4‐(4‐chloro­phenyl)chromano[4,3‐d]‐δ1,9b‐1,2,3‐thia­diazo­line

<i>rac</i>-7-[(2<i>E</i>)-But-2-enoyl]-13-chloro-<i>N</i>-cyclohexyl-7,8-dihydro-5<i>H</i>-isochromeno[4,3-<i>c</i>]phenanthridine-8-carboxamide

1-Acetyl-3'-(4-bromophenyl)-3'-chlorospiro[3H-indole-3,2'-oxetan]-2(1H)-one.

Synthesis and structure of 6′-diethylamino-2′-phenacylaminospiro-[isobenzofuran-1(3H) ,9′-[9H]xanthen]3-one

rac-7-[(2E)-But-2-eno-yl]-13-chloro-N-cyclo-hexyl-7,8-dihydro-5H-isochromeno[4,3-c]phenanthridine-8-carboxamide.

N-(2-Bromophenyl)-2-(4,6-Dimethoxy-Pyrimidin-2-Yloxy)Benzylamine

7-(Benzyloxy)Spiro[2h-1,3-Benzoxazine-2,1 '-Cyclohexan]-4(3h)-One

2-(4,6-Dimethoxypyrimidin-2-ylsulfanyl)-N-phenylbenzamide

Rac-7-[(2e)-but-2-enoyl]-13-chloro-n-cyclohexyl-7,8-dihydro-5h-isochromeno[4,3-c]phenanthridine-8-carboxamide

2-(4-Hydroxybiphenyl-3-yl)isoindolin-1-one

2-[(5-Chloro-2-hydroxybenzylidene)amino]-3′,6′-bis(diethylamino)spiro[isoindoline-1,9′-xanthen]-3-one

2-[(2,4-Dihydroxybenzylidene)amino]-3′,6′-bis(ethylamino)spiro[isoindoline-1,9′-xanthen]-3-one

3′,6′-Bis(ethylamino)-2′,7′-dimethyl-2-{2-(E)-[(thiophen-2-yl)methylideneamino]ethyl}spiro[isoindoline-1,9′-xanthen]-3-one methanol monosolvate

(3ar,6s,7s,7ar)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

(±)‐(3Ars,4sr)‐9‐chloro‐3a,4‐diethoxy‐6,8‐dimethoxy‐2‐(2‐chloro‐4‐nitrophenyl)‐4‐(4‐chlorophenyl)chromano[4,3‐d]‐δ1,9b‐1,2,3‐thiadiazoline